جست‌وجوی استاد و پژوهشگر

Bouke de Jongمشاهده پروفایل

استاد

• Mycobacteriology
• Molecular Epidemiology
• Tuberculosis Research
• +۸ مورد دیگر

Bouke de Jong is a Professor and Unit Head of Mycobacteriology at the Institute of Tropical Medicine in Antwerp, Belgium. She holds a PhD and MD in Medicine, alongside an MSc in Epidemiology from the Netherlands Institute for Health Sciences and the University of Amsterdam. Her research focuses on molecular epidemiology of Mycobacterium species, including tuberculosis (TB), Buruli Ulcer, and leprosy, emphasizing improved diagnostics, treatment optimization, and evaluating public health interventions to curb transmission. Supported by an ERC Starting Grant, she leads a team studying the impact of interventions on disease spread in endemic regions. Education and Academic Qualifications: PhD in Medicine, University of Amsterdam MD in Medicine MSc in Epidemiology, Netherlands Institute for Health Sciences Research Interests: Improved molecular diagnostics for TB, Buruli Ulcer, and leprosy Phylogeography and phylodynamics of Mycobacterium species Optimized treatment regimens for drug-resistant strains Public health strategies to reduce transmission Grant and Project Activity: Dr. de Jong oversees 82 active projects, including ERC-funded research on drug-resistant TB lineages and USAID-supported Tuberculosis Implementation Framework Agreements (TIFA DRC). Notable collaborations involve studies in The Gambia, Rwanda, Niger, the Comoros, and Cuba, addressing TB epidemiology, drug resistance, and clinical intervention efficacy. Scientific Contributions: Her work has advanced understanding of M. africanum, transmission dynamics of M. leprae, and the development of rapid diagnostic methods like ethanol-based RNA preservation and tongue swab culturing. She advocates for global health security funding and participates in clinical trials optimizing treatments for multidrug-resistant infections.

Rajendra Bahadur Shahiمشاهده پروفایل

پژوهشگر

• Cancer Genetics
• Breast Cancer Research
• Lung Cancer
• +۴ مورد دیگر

Rajendra Bahadur Shahi PhD is a researcher at the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), located at Pleinlaan 2, 1050 Brussel, Belgium. With an active research career spanning from 2012 to the present, he has established himself as a significant contributor to cancer genetics research with 11 research outputs documented in institutional records and an h-index reflecting substantial scholarly impact. Dr. Shahi's research primarily focuses on cancer genetics, particularly in the areas of breast and lung cancer predisposition. His work centers on identifying genetic variants that predispose individuals to cancer, with special attention to BRCA1/2-negative familial cases. Using advanced genomic techniques like whole-exome sequencing and next-generation sequencing (NGS), he investigates cancer-associated genes and their mutations to better understand hereditary cancer syndromes and develop improved diagnostic approaches. Analysis of Dr. Shahi's publication record reveals a clear progression from methodological development in NGS approaches toward increasingly sophisticated applications in clinical oncology. His research has evolved from foundational work on sequencing technologies to direct clinical applications in cancer predisposition and targeted therapies, particularly in breast and lung cancer. The integration of genomic data with clinical phenotypes represents a consistent theme throughout his scholarly output. European Association for Cancer Research (EACR) travel fellowship (2012) Organization of the European Cancer Institute (OECI) award (2013) Organization of the European Cancer Institute's (OECI) Award (2011) PhD Scholarship (2011) Prijs Kankeronderzoek (2016) Dr. Shahi has been actively involved in presenting his research at numerous international conferences and workshops, demonstrating his commitment to advancing knowledge in cancer genomics. His scholarly work has garnered attention across multiple platforms, with significant readership on Mendeley and coverage in news outlets, indicating the relevance and impact of his research. He has also contributed to datasets that support reproducible research in cancer genetics. Through his presentations and publications, Dr. Shahi has established himself as a contributor to the cancer research community, particularly in the application of genomic technologies to understand hereditary cancer predisposition. His work bridges basic genomic research with clinical applications, focusing on translating genetic findings into improved cancer risk assessment and potential therapeutic strategies.

Luigi Pannoneمشاهده پروفایل

پزشک-پژوهشگر

• Cardiac Electrophysiology
• Arrhythmia Management
• Catheter Ablation Techniques
• +۳ مورد دیگر

Luigi Pannone is an External employee in the Clinical Sciences department at Brussels University Hospital, specializing in Heart Rhythm Research and Cardiovascular Diseases. He serves as a Physician in Heartrhythmmanagement, contributing significantly to the field of cardiac electrophysiology with a focus on arrhythmia management and ablation techniques. His primary research interests center around cardiac electrophysiology, with particular focus on Brugada Syndrome, Atrial Fibrillation, Catheter Ablation techniques, and Heart Rhythm Disorders. His work has significantly advanced understanding of arrhythmia mechanisms and treatment approaches, particularly in the areas of pulsed field ablation technology and diagnostic techniques for inherited arrhythmia syndromes. He has published extensively on topics ranging from genetic variants in Brugada Syndrome to novel ablation catheter technologies and their clinical applications. Dr. Pannone's recent research output shows a strong emphasis on innovative ablation technologies, particularly pulsed field ablation, with numerous publications examining its safety, efficacy, and applications across various arrhythmia substrates. His work spans from basic mapping studies to large multicenter registries evaluating real-world clinical outcomes. Paul Dudley White International Scholar Award-Belgium (2023) Dr. Pannone serves as an Editor for Frontiers in Cardiovascular Medicine and has contributed to 181 research outputs with 1057 citations and an h-index of 17. His research collaborations span multiple institutions, reflecting his standing in the international cardiac electrophysiology community. His work on the Affera Ventricular Arrhythmia Ablation (AVAAR) Registry and other multicenter studies demonstrates his leadership in clinical research. Dr. Pannone is actively involved in cutting-edge research on heart rhythm management, particularly focusing on novel ablation technologies and their clinical implementation. His work bridges the gap between technological innovation and clinical practice, with a particular emphasis on improving outcomes for patients with complex arrhythmias.

Maxime Cordyمشاهده پروفایل

پژوهشگر

• Software Engineering
• Formal Verification
• Model Checking
• +۴ مورد دیگر

Maxime Cordy is a researcher in Computer Science with a focus on Software Engineering and Formal Verification. He holds a PhD in Computer Science from the University of Namur, earned in 2014, and has engaged in visiting research at the University of Luxembourg (2017-2018). He also co-founded SkalUp as an R&D manager from 2015 to 2016. Education: Doctor of Science (University of Namur, 2014), Master in Computer Science (University of Namur, 2011) His research spans Software Product Lines , Model Checking , and Variability-Intensive Systems , emphasizing formal verification and automated analysis. He has contributed to over 53 research outputs with 949 citations and an h-index of 17. Recent publications include advancements in Featured Transition Systems , Mutation-Based Model Checking , and Machine Learning for Software Quality . He co-organized workshops like MaLTeSQuE 2019 and the Machine Learning and Software Engineering in Symbiosis workshop (2018). Scientific Awards: VAMOS 2024 Ten-Year Most Influential Paper Award (co-recipient) Maxime has collaborated extensively with institutions including the University of Luxembourg and co-authored works with leading researchers in formal methods and software engineering.

• HIV/AIDS
• Sexually Transmitted Infections (STIs)
• Public Health
• +۶ مورد دیگر

Kristien Wouters is a clinical doctor and researcher affiliated with the Institute of Tropical Medicine Antwerp. She works in the HIV/STI-clinic, providing care for patients living with HIV/AIDS and STIs, and coordinates the 'Helpcenter,' a low-threshold center for HIV/STI testing focusing on high-risk groups like migrants and men who have sex with men. Her primary role involves secondary HIV prevention through diagnosis and counseling, alongside primary prevention efforts. She holds a Master's in Medicine from the University of Antwerp and completed a Tropical Medicine specialization at the Institute of Tropical Medicine (2001–2002). Research Focus: Her work emphasizes public health interventions in HIV/STI prevention, epidemiology of antibiotic-resistant pathogens like Mycoplasma genitalium, and healthcare access for marginalized populations. She also investigates outcomes in corneal transplantation and quality-of-life issues in hematological disorders. Recent Research Trends: Recent studies address online self-sampling for HIV/STI testing, barriers to PrEP use among migrants, and antibiotic resistance patterns in bacterial STIs. Her publications span peer-reviewed journals like BMJ Open and Sexually Transmitted Infections . Affiliations & Roles: She serves as Chair of Viva Africa, an external organization. Her work bridges clinical practice, research, and public health advocacy, particularly in Belgium and tropical medicine contexts. Labs/Teams: Active in interdisciplinary teams focused on infectious disease control and global health equity, coordinating multicenter trials and community-based screening initiatives.

• Mycobacteriology
• Tuberculosis
• Antimicrobial Resistance
• +۲ مورد دیگر

Rabab Reenaers is a researcher in the Mycobacteriology unit at the Institute of Tropical Medicine, Antwerp, Belgium. Her work focuses on tuberculosis and Mycobacterium tuberculosis, with expertise in drug susceptibility testing, antimicrobial resistance, and diagnostic methods. She has contributed to multiple publications in high-impact journals including Scientific Reports, Microbiology Spectrum, and Diagnostic Microbiology and Infectious Disease. Her research spans Mycobacteriology, Tuberculosis, Antimicrobial Resistance, Bacterial Genetics, and Drug Susceptibility Testing. She investigates the genetic basis of drug resistance in tuberculosis, evaluates molecular diagnostic tools like GeneXpert MTB/RIF Ultra, and develops optimized culture techniques for Mycobacterium tuberculosis. Her work emphasizes improving tuberculosis diagnosis and treatment in resource-limited settings through laboratory innovations. Analysis of her 2023-2025 publications reveals a concentrated focus on laboratory methodologies for tuberculosis control. Key themes include the impact of Mycobacterium tuberculosis genetic diversity on pretomanid susceptibility, culture isolation from non-invasive samples like tongue swabs, RNA preservation techniques, and detection of rifampicin resistance mutations. Her research bridges fundamental microbiology with clinical applications to enhance global tuberculosis management. Rabab Reenaers operates within the Mycobacteriology research team at the Institute of Tropical Medicine, which maintains extensive international collaborations across Africa and Europe. The team specializes in developing and validating diagnostic protocols, studying drug resistance mechanisms, and contributing to tuberculosis control programs through evidence-based laboratory science.

Anna Jansenمشاهده پروفایل

استاد بالینی

• Neurology
• Medical Genetics
• Malformations of Cortical Development
• +۵ مورد دیگر

Dr. Anna Jansen is a Clinical Professor at Vrije Universiteit Brussel, affiliated with the Faculty of Medicine. She serves as an External employee in both Public Health Sciences and the Department of Genetics Reproduction and Development, with a specialized focus on the Mental Health and Wellbeing research group. Her research spans neurology, genetics, and developmental disorders, with a particular emphasis on malformations of cortical development and their associated neurological conditions. Dr. Jansen's primary research interests center around Malformations of Cortical Development (MCD) , Tuberous Sclerosis Complex , and genetic neurological disorders . Her work investigates the genetic basis of brain malformations, particularly conditions like lissencephaly, polymicrogyria, and tuberous sclerosis. She has made significant contributions to understanding the relationship between specific gene mutations (such as ARX and SUFU) and neurological phenotypes. Her research employs advanced genomic techniques including whole exome and genome sequencing to identify novel genetic variants associated with neurodevelopmental disorders. Analysis of Dr. Jansen's recent publication record reveals a strong focus on translating genetic discoveries into clinical applications. Her work demonstrates an increasing emphasis on patient-centered approaches, interdisciplinary collaboration, and the development of diagnostic protocols for children with developmental disabilities. There's a clear trajectory toward integrating artificial intelligence with clinical neurology, as evidenced by her involvement in multiple AI-focused research projects. Her publications consistently address the intersection of genetics, neurology, and clinical care, with particular attention to improving diagnostic pathways and therapeutic interventions. Dr. Jansen has received several prestigious awards recognizing her contributions to neurology and genetics research: American Academy of Neurology Fellowship (2010) John Stobo Prichard Award (2016) Fonds Jeanne & Alice Van de Voorde for Medical-Scientific Research (2013) As an advisor, Dr. Jansen has supervised or served on committees for 23 master's theses, focusing on topics related to pediatric neurology, developmental disorders, and public health. Her grant portfolio includes 17 major research projects totaling approximately 5 million euros in funding. Notable projects include "TANDem 2: Closing the Gap to Interventions for TAND" (2024-2027), "IOF GEAR: Artificial Intelligence from bench to bedside in neurology" (2022-2026), and "What brain malformations can teach us" (2020-2025). These projects involve interdisciplinary collaborations with institutions across Europe and focus on translating basic research into clinical applications. Dr. Jansen leads the Mental Health and Wellbeing research group at Vrije Universiteit Brussel, which comprises 15 researchers including geneticists, neurologists, and bioinformaticians. Her team collaborates extensively with the University Hospitals Leuven and other European institutions through multiple EU-funded initiatives. The group maintains strong partnerships with patient advocacy organizations, particularly those focused on tuberous sclerosis and cortical malformation disorders, ensuring that research priorities align with patient needs.

• Fatty Liver
• Stem Cells
• Hepatocytes
• +۴ مورد دیگر

Joost Boeckmans is a postdoctoral researcher at the Faculty of Medicine and Pharmacy , Vrije Universiteit Brussel, Belgium. His work focuses on stem cell-based in vitro models for studying liver diseases, drug responses, and toxicology. He is affiliated with the In Vitro Toxicology and Dermato-Cosmetology department and holds a Researcher title. Education: PhD in Pharmaceutical and Pharmacological Sciences (2020), Master's in Pharmaceutical Sciences (2016, 2018), Master's in Pharmaceutical Sciences (2024). Joost's research spans non-alcoholic fatty liver disease (NAFLD/NASH) , genetic predisposition in drug response , in vitro toxicology , and adverse outcome pathways . His work integrates human stem cells , polygenic risk scores , and thyroid hormone signaling to develop drug testing platforms. Recent publications (2025) explore MASLD/ALD cirrhosis outcomes , PNPLA3 I148M mutation in liver injury, and anti-MAFLD drug development . Key article trends include genetic mediators (ANGPTL4, PDK4, PLIN2) , in vitro model optimization , and cross-disease comparisons (ALD vs. MASLD) . His scientific awards include: Colgate-Palmolive postdoctoral fellowship (2023) National Award of the Belgian Society of Pharmaceutical Sciences (2021) Poster prizes at Global NASH Congress (2019) and BelTox/IC-3Rs/INVITROM Joint Symposium (2019) Joost collaborates on projects like FWOSB134 (anti-MAFLD drugs) and AIIFUND101 (PRS-HFC for drug responses). He has presented at conferences in 2022-2024 , including talks on anti-MASH drug response and liver steatosis AOP networks .

• Genetic Hemostasis Disorders
• Thrombophilia
• Platelet Biology
• +۳ مورد دیگر

Kathleen Freson is a Professor at the Faculty of Medicine , KU Leuven. She serves as Director of the Biomedical Sciences Doctoral School and Head of the Center for Molecular and Vascular Biology . Her research focuses on genetic hemostasis disorders , thrombophilia , and inherited platelet defects , with emphasis on genotype-phenotype correlations and omics-based disease modeling . Key projects: Multigene panels for thrombophilia, whole-genome sequencing for platelet disorders, functional assessment of anticoagulant variants Her recent publications address venous thromboembolism epidemiology , neurodevelopmental disorders linked to snRNA mutations , and clinical applications of genetic sequencing in bleeding diseases . She collaborates with institutions like the KU Leuven Institute for Rare Diseases and contributes to ISTH nomenclature guidelines .

• Cardiology
• Electrophysiology
• Heart Rhythm Disorders
• +۴ مورد دیگر

Gaetano Paparella is a Physician Scientist specializing in heart rhythm management and cardiovascular diseases at the Department of Cardiology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel. He maintains clinical practice at University Hospital Brussels (UZB) located at Laarbeeklaan 101, 1090 Jette, Belgium, with strong research integration into his clinical work. His primary research interests focus on cardiac electrophysiology, particularly atrial fibrillation and Brugada syndrome. His work spans diagnostic approaches, genetic testing implications, and innovative treatment strategies for cardiac arrhythmias. He has made significant contributions to understanding the relationship between genetic mutations and clinical manifestations in arrhythmia syndromes. Analysis of his 86 publications reveals consistent research focus on cardiac rhythm disorders, with particular emphasis on the application of advanced imaging techniques like speckle-tracking echocardiography and electrocardiographic imaging. His work demonstrates increasing collaboration with international research groups, particularly in genetic studies of arrhythmia syndromes. His research output shows steady productivity with 11 publications in 2021 and 2022, demonstrating ongoing active engagement in the field. The publication trend indicates growing focus on genetic aspects of arrhythmia syndromes alongside traditional electrophysiology research. Dr. Paparella maintains extensive collaborative relationships with leading European electrophysiologists including Pannone L., Sarkozy A., Brugada P., Chierchia G.B., and de Asmundis C., contributing to multicenter studies and registry-based research that has influenced clinical practice guidelines.

Gilles Perrouinمشاهده پروفایل

استاد پژوهشی

• Software Engineering
• Testing
• Artificial Intelligence
• +۳ مورد دیگر

Gilles Perrouin is a Research Professor in the Faculty of Computer Science at the University of Namur, affiliated with the Research Center on Information Systems Engineering and the Namur Digital Institute. His expertise spans Software Engineering, Testing, Artificial Intelligence, and Machine Learning, with a focus on software product lines, configuration management, and automated testing techniques. He leads projects such as SQUAL.AI (Software Quality through Artificial Intelligence) and SmartTune (Hyper-parameter Optimization for Deep Learning). Perrouin has received awards including the Distinguished Reviewer Award (2023 and 2019) and the VAMOS 2024 ten-year Most Influential Paper Award. He actively participates in organizing conferences like the Belgium-Netherlands Software Evolution Workshop and contributes to initiatives promoting diversity in science, such as Women and Girls in Science events. His research involves advancing testing methodologies for complex systems, exploring energy-efficient neural architectures, and addressing fairness in machine learning. Collaborations span international institutions, reflecting his global impact in software engineering and AI.

Karen Sermonمشاهده پروفایل

استاد

• Human Embryonic Stem Cells
• Preimplantation Diagnosis
• Genetics of Infertility
• +۵ مورد دیگر

Karen Sermon is a distinguished Professor at Vrije Universiteit Brussel's Faculty of Medicine and Pharmacy, specializing in the Department of Basic Medical Sciences. With over three decades of research activity documented since 1990, she leads multiple active research projects including FWOTM1228 on Hippo signaling in embryo development and HERC66 on 3D cellular imaging. Her work has resulted in an impressive 302 research outputs, 49 projects, and 58 h-index based on Scopus citations. Dr. Sermon's research focuses on human embryonic stem cells, preimplantation diagnosis, chromosomal abnormalities, and the genetic components of infertility. Her fingerprint reveals expertise in Preimplantation Diagnosis (100%), Human Embryonic Stem Cells (54%), and Embryonic Structures (28%). She has made significant contributions to understanding chromosomal abnormalities in early embryo development and their impact on differentiation potential. Analysis of her 15 most recent publications shows a consistent focus on chromosomal abnormalities in human pluripotent stem cells and early embryo development. Her research examines how specific chromosomal aberrations affect stem cell differentiation, particularly in neuroectoderm and retinal pigment epithelium lineages. Recent work also explores mitochondrial DNA variants in relation to assisted reproductive technologies and their impact on birth outcomes. Award-winning oral presentation (1998) Prize Dr. José Daels (2005) Serono Award (1989) Dr. Sermon has supervised numerous doctoral and master's students including Markouli, C. (2013), Duggal, G. (2015), Baldan, J. (2020), Segers, S. (2019), and Popovic, M. (2019). She currently serves as a supervisor for Marius Regin's PhD research on regulators of cell fate decisions. Her research is supported by multiple grants including FWOTM1228, HERC66, BASGO23, and OZRMETH9, totaling 49 projects with significant funding for fundamental research in reproductive genetics and embryology. She is actively involved in major collaborative research networks, particularly in the GRAD research group, and has established significant partnerships with researchers across Europe. Her laboratory work focuses on human pre-implantation embryo development, chromosomal abnormalities in cleavage-stage embryos, and the genetic components of infertility and early developmental failure.

• Mitochondrial DNA
• Mitochondrial Genome
• Mutation
• +۷ مورد دیگر

Ben Caljon is an active Researcher at Vrije Universiteit Brussel in the Department of Genetics, Reproduction and Development within the School of Clinical Sciences. With an h-index of 243 and 35 research outputs spanning from 2012 to 2024, his work demonstrates significant scholarly impact in medical genetics and related fields. Dr. Caljon's research interests center around mitochondrial DNA, mitochondrial genome analysis, genetic mutations, Klinefelter Syndrome, and exome sequencing. His work spans multiple disciplines within medical genetics, with particular focus on reproductive genetics, oncogenetics, and diagnostic applications of genomic technologies. His fingerprint analysis shows strong concentration in Mitochondrial DNA (100%), Mitochondrial Genome (87%), and Mutation research (50%). Recent publication trends indicate active involvement in neurodevelopmental disorders, cancer genetics, reproductive medicine, and immunotherapy research. His 2024 publications include work on NSRP1-associated neurodevelopmental disorders and intracranial immunotherapy for glioma, demonstrating breadth across clinical genetics and oncology. Dr. Caljon actively participates in academic conferences and workshops, including the Belgian Society of Human Genetics meetings and specialized workshops on comparative genomics and epigenetics. His collaborative network extends across multiple research institutions, with significant contributions to datasets related to cancer predisposition and reproductive genetics.

Hilde Smetمشاهده پروفایل

پژوهشگر

• Microbiology
• Infectious Diseases
• Sexually Transmitted Infections
• +۴ مورد دیگر

Hilde Smet is a Researcher at the Institute of Tropical Medicine Antwerp (ITM) Clinical Reference Laboratory in Belgium, with a significant research focus on sexually transmitted infections, particularly Mycoplasma genitalium and antimicrobial resistance patterns. Her work spans clinical microbiology, public health surveillance, and diagnostic methodology development, with strong international collaborations across Europe and Africa. Her research interests center on infectious disease diagnostics , with specific expertise in antimicrobial resistance surveillance , STI epidemiology , and molecular detection methods . Dr. Smet's work has been particularly influential in understanding resistance patterns in Mycoplasma genitalium across different population groups, including men who have sex with men and populations in West Africa. Her publication record shows consistent research activity from 2012-2024, with a notable increase in output since 2018. The research demonstrates strong methodological rigor with frequent use of molecular diagnostics, epidemiological analysis, and public health surveillance approaches. Her work on monkeypox virus detection during the 2022 outbreak contributed significantly to understanding asymptomatic transmission patterns. Picked up by 30 news outlets Blogged by 2 sources Referenced in 1 policy source Posted by 174 X users Featured on 1 Facebook page Referenced in 2 Wikipedia pages Dr. Smet collaborates extensively with researchers across multiple institutions, particularly focusing on sexual health clinics and reference laboratory networks. Her work often involves large collaborative studies like the CohMSM-PrEP ANRS 12369 study examining STIs among men who have sex with men using pre-exposure prophylaxis in West Africa. The Clinical Reference Laboratory at ITM serves as the central hub for her research activities, providing the diagnostic and methodological expertise that underpins her publications.

Sonia Van Doorenمشاهده پروفایل

پژوهشگر

• Cardiogenetics
• Molecular Genetics
• Genetic Testing
• +۳ مورد دیگر

Sonia Van Dooren is a Researcher at Vrije Universiteit Brussel (VUB), affiliated with the Genetics Reproduction and Development department. She holds external roles as Coordinator of the Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore) and Lab supervisor at Universitair Ziekenhuis Brussel (UZ Brussel). Her expertise lies in molecular genetics, with a focus on cardiogenetics, multi-omics research, and innovative clinical laboratory techniques. She earned a PhD in Virology from Utrecht University (2005) and a Medical Genetics certificate from VUB (2009). Her research spans Brugada Syndrome, genetic testing, and cardiac arrhythmias. Notable projects include TumorScope (AI-driven healthcare) and ANTICIPATE (epidemic modeling). She actively participates in academic conferences and workshops, contributing to policy and educational initiatives in genetics. Van Dooren’s work integrates genomics and clinical outcomes, emphasizing disease-specific patient-reported measures. She oversees labs and collaborates internationally, advancing diagnostics and AI applications in medicine.